$RMTG
Regenerative Medical Technology Group Inc. Stock $rmtg

$rmtg Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023029942 Filed on April 14, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$786.2K	$541.3K	$1.530M
YoY Change	153.55%	86.64%	7470.86%
Cost Of Revenue	$249.4K	$184.4K	$653.3K
YoY Change	22.5%	-14.16%	97.96%
Gross Profit	$536.8K	$356.9K	$877.0K
YoY Change	404.09%	374.72%	484.64%
Gross Profit Margin	68.28%	65.93%	57.31%
Selling, General & Admin	$73.00	$421.1K	$8.200M
YoY Change	-99.99%	-24.45%	-18.33%
% of Gross Profit	0.01%	118.01%	935.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$56.63K	$50.56K	$152.7K
YoY Change	109.89%	83.79%	281.85%
% of Gross Profit	10.55%	14.17%	17.42%
Operating Expenses	$611.0K	$471.7K	$2.062M
YoY Change	-5.85%	-19.36%	-79.55%
Operating Profit	-$74.21K	-$114.8K	-$1.185M
YoY Change	-86.32%	-77.47%	-88.07%
Interest Expense	-$1.599M	-$945.9K	-$4.390M
YoY Change	40.91%	-10.84%	61.41%
% of Operating Profit
Other Income/Expense, Net	$503.6K		$503.6K
YoY Change	-144.15%
Pretax Income	-$1.670M	-$1.061M	-$5.575M
YoY Change	-0.4%	-32.47%	-56.71%
Income Tax			-$1.156M
% Of Pretax Income
Net Earnings	-$1.670M	-$992.4K	-$5.507M
YoY Change	-0.4%	-36.82%	-57.25%
Net Earnings / Revenue	-212.45%	-183.35%	-359.87%
Basic Earnings Per Share	-$0.13		-$0.45
Diluted Earnings Per Share	-$0.13	-$0.09	-$0.45
COMMON SHARES
Basic Shares Outstanding	12.44M shares	12.25M shares	12.22M shares
Diluted Shares Outstanding	12.44M shares		12.22M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.637M	$1.645M	$1.645M
YoY Change	-33.5%	-44.77%	-44.79%
Cash & Equivalents	$1.637M	$1.645M	$1.645M
Short-Term Investments
Other Short-Term Assets		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Inventory
Prepaid Expenses
Receivables	$102.8K	$49.77K	$49.77K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.739M	$1.695M	$1.695M
YoY Change	-34.18%	-43.88%	-43.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$159.5K	$186.3K	$220.2K
YoY Change	110.27%	713.08%	1001.15%
Goodwill	$5.805M	$5.805M
YoY Change		0.0%
Intangibles	$329.7K	$354.1K
YoY Change		-21.6%
Long-Term Investments
YoY Change
Other Assets	$5.570K	$5.570K	$5.570K
YoY Change	0.0%	0.0%	-44.3%
Total Long-Term Assets	$6.327M	$6.385M	$6.385M
YoY Change	0.19%	1.59%	1.52%
TOTAL ASSETS
Total Short-Term Assets	$1.739M	$1.695M	$1.695M
Total Long-Term Assets	$6.327M	$6.385M	$6.385M
Total Assets	$8.066M	$8.080M	$8.080M
YoY Change	-9.95%	-13.17%	-13.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$374.0K	$245.5K	$245.5K
YoY Change	-1.14%	-2.11%	-1.82%
Accrued Expenses	$5.431M	$4.658M	$4.690M
YoY Change	91.67%	118.73%	120.19%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due	$7.070M	$7.047M	$7.047M
YoY Change	360.77%	361.26%	360.57%
Total Short-Term Liabilities	$12.93M	$12.00M	$12.00M
YoY Change	167.95%	184.48%	184.35%
LONG-TERM LIABILITIES
Long-Term Debt	$8.792M	$8.062M	$8.062M
YoY Change	-28.42%	-31.94%	-31.91%
Other Long-Term Liabilities	$0.00	$1.400K	$1.400K
YoY Change	-100.0%
Total Long-Term Liabilities	$8.792M	$8.063M	$8.063M
YoY Change	-28.55%	-31.93%	-31.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.93M	$12.00M	$12.00M
Total Long-Term Liabilities	$8.792M	$8.063M	$8.063M
Total Liabilities	$21.72M	$20.06M	$20.06M
YoY Change	26.79%	24.9%	24.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$53.85M	-$52.18M
YoY Change		11.8%
Common Stock	$12.44K	$12.44K
YoY Change		2.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$13.65M	-$11.98M	-$11.98M
YoY Change
Total Liabilities & Shareholders Equity	$8.066M	$8.080M	$8.080M
YoY Change	-9.95%	-13.17%	-13.21%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.670M	-$992.4K	-$5.507M
YoY Change	-0.4%	-36.82%	-57.25%
Depreciation, Depletion And Amortization	$56.63K	$50.56K	$152.7K
YoY Change	109.89%	83.79%	281.85%
Cash From Operating Activities	$6.775K	-$49.43K	-$1.114M
YoY Change	-101.31%	-99.44%	-88.72%
INVESTING ACTIVITIES
Capital Expenditures	$5.486K	$68.53K	$198.4K
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$5.486K	-$68.53K	-$198.4K
YoY Change		37972.22%	-129.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$9.850K	-6.500K	-$20.78K
YoY Change	603.57%	-100.65%	-100.17%
NET CHANGE
Cash From Operating Activities	$6.775K	-49.43K	-$1.114M
Cash From Investing Activities	-$5.486K	-68.53K	-$198.4K
Cash From Financing Activities	-$9.850K	-6.500K	-$20.78K
Net Change In Cash	-$8.561K	-124.5K	-$1.333M
YoY Change	-98.35%	-98.39%	-145.35%
FREE CASH FLOW
Cash From Operating Activities	$6.775K	-$49.43K	-$1.114M
Capital Expenditures	$5.486K	$68.53K	$198.4K
Free Cash Flow	$1.289K	-$118.0K	-$1.313M
YoY Change	-100.25%		-86.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-56010
CY2022	dei	Entity Registrant Name EntityRegistrantName	MESO NUMISMATICS, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-0492191
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	433 Plaza Real Suite 275
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Boca Raton
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33432
CY2022	dei	City Area Code CityAreaCode	(800)
CY2022	dei	Local Phone Number LocalPhoneNumber	956-3935
CY2022	dei	Security12b Title Security12bTitle	None
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	612544	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12443938	shares
CY2022	dei	Trading Symbol TradingSymbol	MSSV
CY2022	dei	Auditor Name AuditorName	L J Soldinger Associates, LLC
CY2022	dei	Auditor Location AuditorLocation	Deer Park, Illinois
CY2022	dei	Auditor Firm AuditorFirmId	318
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1645185	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2978525	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	49766	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	17256	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	24245	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1694951	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	3020027	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	186269	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22909	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	5568	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	5568	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	354084	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	451624	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33963	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5805438	usd
CY2021Q4	us-gaap	Goodwill Goodwill	5805438	usd
CY2022Q4	us-gaap	Assets Assets	8080273	usd
CY2021Q4	us-gaap	Assets Assets	9305566	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	245463	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	181442	usd
CY2021Q4	mssv	Liabilities Held For Sale LiabilitiesHeldForSale	69314	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4657530	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2129395	usd
CY2022Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	10450	usd
CY2021Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	18215	usd
CY2021Q4	mssv	Stock Payablerelated Party StockPayablerelatedParty	251536	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	6944	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	20442	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	32568	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7046666	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1527711	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11999621	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4218055	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1395	usd
CY2022Q4	mssv	Convertible Notes Payable Net Of Discount ConvertibleNotesPayableNetOfDiscount	37419	usd
CY2021Q4	mssv	Convertible Notes Payable Net Of Discount ConvertibleNotesPayableNetOfDiscount	33982	usd
CY2022Q4	mssv	Notes Payablerelated Parties Non Current NotesPayablerelatedPartiesNonCurrent	7800	usd
CY2021Q4	mssv	Notes Payablerelated Parties Non Current NotesPayablerelatedPartiesNonCurrent	7800	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	8016330	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	11802736	usd
CY2022Q4	us-gaap	Liabilities Liabilities	20062565	usd
CY2021Q4	us-gaap	Liabilities Liabilities	16062573	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1050	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	1050	usd
CY2022Q4	mssv	Preferred Stock Value1 PreferredStockValue1	10	usd
CY2021Q4	mssv	Preferred Stock Value1 PreferredStockValue1	10	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5575135	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-12871273	usd
CY2022	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	68313	usd
CY2021	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-13207	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	68313	usd
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-13207	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14046252	shares
CY2022Q4	mssv	Common Stock Shares Issuable CommonStockSharesIssuable	14046252	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13687439	shares
CY2021Q4	mssv	Common Stock Shares Issuable CommonStockSharesIssuable	13687439	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12443938	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12085125	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12444	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	12086	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40180669	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39899491	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52176465	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-46669643	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11982292	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-6757007	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8080273	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9305566	usd
CY2022	us-gaap	Revenues Revenues	1530223	usd
CY2021	us-gaap	Revenues Revenues	437887	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	653256	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	287750	usd
CY2022	us-gaap	Gross Profit GrossProfit	876967	usd
CY2021	us-gaap	Gross Profit GrossProfit	150137	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	317796	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	133451	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	886651	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	966974	usd
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	90000	usd
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	563072	usd
CY2022	us-gaap	Depreciation Depreciation	152739	usd
CY2021	us-gaap	Depreciation Depreciation	40058	usd
CY2022	mssv	Investor Relations InvestorRelations	190382	usd
CY2021	mssv	Investor Relations InvestorRelations	100496	usd
CY2021	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	8116269	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	424258	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	149374	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	2061826	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	10069694	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4403774	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2724351	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	13498	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3744	usd
CY2021	mssv	Settlement Of Lawsuit SettlementOfLawsuit	-231109	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5506822	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12884480	usd
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.46
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.12
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.01
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12219502	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11482399	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-6757007	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	30000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	251536	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5506822	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11982292	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-6409571	usd
CY2021	mssv	Debt Settlement DebtSettlement	213109	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	30000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	251536	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	963866	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5038576	usd
CY2021	mssv	Stock Issued During Period Value Imputed Interest On Debt StockIssuedDuringPeriodValueImputedInterestOnDebt	-24186	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	6064144	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12884480	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-6757007	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5575135	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-12871273	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1756764	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	893959	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	152739	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	40858	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	13498	usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	3744	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	10000	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	30000	usd
CY2021	mssv	Loss On Legal Settlement LossOnLegalSettlement	213109	usd
CY2021	mssv	Preferred Shares Issued For Services PreferredSharesIssuedForServices	251536	usd
CY2021	mssv	Imputed Interest On Debt ImputedInterestOnDebt	34237	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32510	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3250	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	24245	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5568	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2517791	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1307388	usd
CY2021	mssv	Increase Decrease Stock Payable IncreaseDecreaseStockPayable	271536	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1183849	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-9865457	usd
CY2022	mssv	Depreciation Discontinued Operations DepreciationDiscontinuedOperations	1400	usd
CY2022	mssv	Gainloss On Discontinued Operations GainlossOnDiscontinuedOperations	68313	usd
CY2021	mssv	Gainloss On Discontinued Operations GainlossOnDiscontinuedOperations	-13207	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	69713	usd
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-13207	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1114136	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9878664	usd
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	666467	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	198428	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-198428	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	666467	usd
CY2021	mssv	Proceeds From Note Receivable ProceedsFromNoteReceivable	-12400000	usd
CY2021	mssv	Loan To Nonaffiliate LoanToNonaffiliate	250000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	20776	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	1812	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20776	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12148188	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1333340	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2935991	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2978525	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42534	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1645185	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2978525	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	283	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	208	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	271536	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	62903	usd
CY2021	mssv	Debt Restructure DebtRestructure	5703537	usd
CY2021	mssv	Cancellations Of Preferred Series Bb CancellationsOfPreferredSeriesBB	279	usd
CY2021	mssv	Cancellation Of Preferred Series Cc CancellationOfPreferredSeriesCC	83731	usd
CY2021	mssv	Issuance Of Preferred Series Aa For Acquisition IssuanceOfPreferredSeriesAAForAcquisition	963866	usd
CY2021	mssv	Issuance Of Preferred Series Dd For Acquisitions IssuanceOfPreferredSeriesDDForAcquisitions	5038576	usd
CY2021	mssv	Discount Issued On Convertible Debt DiscountIssuedOnConvertibleDebt	1200000	usd
CY2017Q3	mssv	Share Issuance Of Series Bb Preferred ShareIssuanceOfSeriesBBPreferred	25000	shares
CY2018Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On July 2, 2018, the Board of Directors authorized and shareholders approved a 1-for-1,000 reverse stock split of its issued and outstanding shares of common stock held by the holders of record. The prior year financials have been changed to reflect the 1-for-1,000 reverse stock split.
CY2021Q3	mssv	Purchase Agreement Acquiring Description PurchaseAgreementAcquiringDescription	On August 18, 2021, Meso Numismatics, Inc., completed its acquisition of Global Stem Cells Group Inc., through a Stock Purchase Agreement acquiring all the outstanding capital stock of Global Stem Cells Group Inc and paid the purchase price of a total of 1,000,000 shares of Series AA Preferred Stock in the Company, 8,974 shares of Series DD Preferred Stock in the Company and $225,000 USD (the final payment of $50,000 was made on July 2, 2021).
CY2022Q4	us-gaap	Shares Issued SharesIssued	1000	shares
CY2022	mssv	Cash Payments CashPayments	8200000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8200000	usd
CY2022Q4	mssv	Interest Percentages InterestPercentages	1	pure
CY2022	us-gaap	Liabilities Average Amount Outstanding LiabilitiesAverageAmountOutstanding	66255	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><i>Use of Estimates in Financial Statement Presentation</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The significant estimates included in these financial statements are associated with accounting for the goodwill, derivative liability, valuation of preferred stock, and for the valuation of assets and liabilities in business combination.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><i> </i></span></p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><i>Reclassifications</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Certain amounts for the prior year have been revised or reclassified to conform to the current year presentation. No change in net loss resulted from these reclassifications.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i> </i></span></p>
CY2022	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2022Q4	mssv	Convertible Notes Outstanding ConvertibleNotesOutstanding	365463	shares
CY2021Q4	mssv	Convertible Notes Outstanding ConvertibleNotesOutstanding	75710	shares
CY2022Q4	mssv	Convertible Preferred Stock Outstanding ConvertiblePreferredStockOutstanding	39447283	shares
CY2021Q4	mssv	Convertible Preferred Stock Outstanding ConvertiblePreferredStockOutstanding	37647060	shares
CY2022Q4	mssv	Shares Underlying Warrants Outstanding SharesUnderlyingWarrantsOutstanding	103500000	shares
CY2021Q4	mssv	Shares Underlying Warrants Outstanding SharesUnderlyingWarrantsOutstanding	103500000	shares
CY2022Q4	mssv	Total Outstanding TotalOutstanding	143312746	shares
CY2021Q4	mssv	Total Outstanding TotalOutstanding	141222770	shares
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	6944	usd
CY2022Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	6944	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	20422	usd
CY2021Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	20422	usd
CY2022	us-gaap	Revenues Revenues	1530223	usd
CY2021	us-gaap	Revenues Revenues	437887	usd
CY2022	mssv	Going Concern GoingConcern	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>Going Concern</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The financial statements have been prepared assuming the Company will continue as a going concern. The Company has incurred losses since inception, resulting in an accumulated deficit of $52,176,465 and a working capital deficit of $10,304,670 as of December 31, 2022 and future losses are anticipated. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The ability of the Company to continue its operations as a going concern is dependent on management’s plans, which include the raising of capital through debt and/or equity markets with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company will require additional funding to finance the growth of its current and expected future operations as well to achieve its strategic objectives. There can be no assurance that financing will be available in amounts or terms acceptable to the Company, if at all. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.</span></p>
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52176465	usd
CY2022Q4	mssv	Working Capital Deficit WorkingCapitalDeficit	10304670	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1530223	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	653256	usd
CY2022	mssv	Revenue Gross Profits RevenueGrossProfits	876966	usd
CY2022	mssv	Gross Profits GrossProfits	0.5731	pure
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue	8080273	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5506822	usd
CY2019Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.2
CY2019Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	81043	shares
CY2019Q4	mssv	Aggregate Exchange Amount AggregateExchangeAmount	97252	usd
CY2022	mssv	Payments On The Outstanding Convertible Notes PaymentsOnTheOutstandingConvertibleNotes	15000	usd
CY2021	mssv	Payments On The Outstanding Convertible Notes PaymentsOnTheOutstandingConvertibleNotes	25000	usd
CY2022	us-gaap	Deferred Policy Acquisition Cost Amortization Expense Other DeferredPolicyAcquisitionCostAmortizationExpenseOther	18437	usd
CY2021	us-gaap	Deferred Policy Acquisition Cost Amortization Expense Other DeferredPolicyAcquisitionCostAmortizationExpenseOther	19482	usd
CY2022	mssv	Outstanding Convertible Notes OutstandingConvertibleNotes	15000	usd
CY2021	mssv	Outstanding Convertible Notes OutstandingConvertibleNotes	25000	usd
CY2015	mssv	Maturity Term MaturityTerm	P1Y
CY2019Q4	mssv	Premium Paid PremiumPaid	0.20	pure
CY2020Q4	mssv	Shares Exchanged SharesExchanged	5379624	usd
CY2020Q4	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	5379624	usd
CY2020Q4	us-gaap	Stock Issued During Period Shares Employee Stock Ownership Plan StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan	15000000	shares
CY2020Q4	mssv	Aggregate Principal Amount AggregatePrincipalAmount	5379624	usd
CY2020Q4	mssv	Debt Instrument Bears Interest Rate DebtInstrumentBearsInterestRate	0.15	pure
CY2020Q4	mssv	Cashless Warrants Purchased CashlessWarrantsPurchased	15000000	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.03
CY2020Q4	mssv	Warrants Issued WarrantsIssued	15000000	shares
CY2020Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	262376	usd
CY2022	mssv	Aggregate Loan Balances Outstanding AggregateLoanBalancesOutstanding	5379624	usd
CY2021	mssv	Aggregate Loan Balances Outstanding AggregateLoanBalancesOutstanding	5379624	usd
CY2022Q4	mssv	Unamortized Discount UnamortizedDiscount	81700	usd
CY2021Q4	mssv	Unamortized Discount UnamortizedDiscount	169168	usd
CY2020Q4	mssv	Promissory Bebentures Lender Amount PromissoryBebenturesLenderAmount	110000	usd
CY2020Q4	mssv	Annual Interest Rate AnnualInterestRate	0.15	pure
CY2020Q4	mssv	Cashless Warrants Purchased CashlessWarrantsPurchased	1000000	shares
CY2020Q4	mssv	Advanced Total AdvancedTotal	100000	usd
CY2021Q4	us-gaap	Other Deferred Costs Gross OtherDeferredCostsGross	82466	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	15070796	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	13338247	usd
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	10000	usd
CY2020Q4	mssv	Warrants Issued WarrantsIssued	1000000	shares
CY2020Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	17491	usd
CY2021Q1	mssv	Promissory Bebentures Lender Amount PromissoryBebenturesLenderAmount	1000000	usd
CY2021Q1	mssv	Annual Interest Rate AnnualInterestRate	0.15	pure
CY2021Q1	mssv	Cashless Warrants Purchased CashlessWarrantsPurchased	10000000	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.03
CY2021Q1	mssv	Advanced Total AdvancedTotal	900000	usd
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	100000	usd
CY2021Q1	mssv	Warrants Issued WarrantsIssued	10000000	shares
CY2021Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	237811	usd
CY2021Q2	mssv	Promissory Bebentures Lender Amount PromissoryBebenturesLenderAmount	11600000	usd
CY2021Q2	mssv	Annual Interest Rate AnnualInterestRate	0.12	pure
CY2021Q2	mssv	Cashless Warrants Purchased CashlessWarrantsPurchased	70000000	shares
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2021Q2	mssv	Advanced Total AdvancedTotal	10500000	usd
CY2021Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1100000	usd
CY2021Q2	mssv	Warrants Issued WarrantsIssued	70000000	shares
CY2021Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	5465726	usd
CY2021Q3	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	20991	usd
CY2021Q3	mssv	Interest Rate InterestRate	0.0899	pure
CY2022Q4	mssv	Interest Monthly Payments InterestMonthlyPayments	504.94	usd
CY2021Q3	mssv	Promissory Bebentures Lender Amount PromissoryBebenturesLenderAmount	1100000	usd
CY2021Q3	mssv	Annual Interest Rate AnnualInterestRate	0.12	pure
CY2021Q3	mssv	Cashless Warrants Purchased CashlessWarrantsPurchased	7500000	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.085
CY2021Q3	mssv	Advanced Total AdvancedTotal	1000000	usd
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	100000	usd
CY2021Q3	mssv	Warrants Issued WarrantsIssued	7500000	shares
CY2021Q3	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	360607	usd
CY2021Q4	mssv	Promissory Bebentures Lender Amount PromissoryBebenturesLenderAmount	84000	usd
CY2021Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	22162	usd
CY2021Q4	mssv	Premium Percent PremiumPercent	0.05	pure
CY2021	us-gaap	Premiums Earned Net Life PremiumsEarnedNetLife	111470	usd
CY2021	mssv	Debt Instrument Bears Interest Rate DebtInstrumentBearsInterestRate	0.12	pure
CY2022	mssv	Promissory Notes Payable PromissoryNotesPayable	20237559	usd
CY2021	mssv	Promissory Notes Payable PromissoryNotesPayable	20243335	usd
CY2022	mssv	Promissory Notes Payable Discount PromissoryNotesPayableDiscount	5117631	usd
CY2021	mssv	Promissory Notes Payable Discount PromissoryNotesPayableDiscount	6822622	usd
CY2022Q4	us-gaap	Other Deferred Costs Gross OtherDeferredCostsGross	49132	usd
CY2022	us-gaap	Dividends Share Based Compensation Cash DividendsShareBasedCompensationCash	5776	usd
CY2021	us-gaap	Dividends Share Based Compensation Cash DividendsShareBasedCompensationCash	1812	usd
CY2022	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	2898155	usd
CY2021	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	1781394	usd
CY2022Q4	us-gaap	Amortization Expense Per Dollar Of Gross Revenue AmortizationExpensePerDollarOfGrossRevenue	1738327	usd
CY2021Q4	us-gaap	Amortization Expense Per Dollar Of Gross Revenue AmortizationExpensePerDollarOfGrossRevenue	874476	usd
CY2022Q4	mssv	Outstanding Promissory Notes Payable OutstandingPromissoryNotesPayable	20237559	usd
CY2021Q4	mssv	Outstanding Promissory Notes Payable OutstandingPromissoryNotesPayable	20243335	usd
CY2022	mssv	Common Stock Issuablein Shares CommonStockIssuableinShares	365463	shares
CY2022	mssv	Market Value Of Common Stock On Measurement Datein Dollars MarketValueOfCommonStockOnMeasurementDateinDollars	0.019
CY2022	mssv	Adjusted Exercise Pricein Dollars Per Share AdjustedExercisePriceinDollarsPerShare	0.06
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0434	pure
CY2022	mssv	Instrument Lives In Years InstrumentLivesInYears	P2Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.79	pure
CY2021	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions	24186	usd
CY2021Q4	mssv	Gain On Derivative Instruments GainOnDerivativeInstruments	-3744	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	20442	usd
CY2022Q4	mssv	Gain On Derivative Instruments GainOnDerivativeInstruments	-13448	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	6944	usd
CY2022	us-gaap	Debt Conversion Description DebtConversionDescription	At any time prior to November 25, 2022 (“Automatic Conversion Date”) the Company may redeem for cash out of funds legally available therefor, any or all of the outstanding Series CC Convertible Preferred Stock at a price equal to $1,000 per share. If not converted prior, on the Automatic Conversion Date, any and all remaining issued and outstanding shares of Series CC Convertible Preferred Stock shall automatically convert at the Conversion Price, which is a price per share determined by dividing the number of issued and outstanding shares of common stock of the Company on the date of conversion by 1,000 and multiply the results by 0.8.
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.03
CY2020	mssv	Issuance Of Warrants IssuanceOfWarrants	16000000	shares
CY2021Q1	mssv	Issuance Of Warrants IssuanceOfWarrants	10000000	shares
CY2021Q1	mssv	Warrants Issued For Debt WarrantsIssuedForDebt	237811	usd
CY2021Q2	mssv	Issuance Of Warrants IssuanceOfWarrants	70000000	shares
CY2021Q2	mssv	Warrants Issued For Debt WarrantsIssuedForDebt	5465726	usd
CY2021Q3	mssv	Issuance Of Warrants IssuanceOfWarrants	7500000	shares
CY2021Q3	mssv	Warrants Issued For Debt WarrantsIssuedForDebt	360607	usd
CY2022	mssv	Aggregate Vote AggregateVote	0.67	pure
CY2021Q3	mssv	Final Payment FinalPayment	225000	usd
CY2021Q3	mssv	Final Payment FinalPayment	50000	usd
CY2022	mssv	Convertible Common Stock Description ConvertibleCommonStockDescription	The Series AA Preferred shares issued on August 18, 2021, were valued based upon industry specific control premiums and the Company’s market cap at the time of the transaction. The $963,866 value of the 1,000,000 shares of Series AA Super Voting Preferred Stock issued to Benito Novas were valued based on a calculation by a third party independent valuation specialist.
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1050000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1050000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	mssv	Payment Amount PaymentAmount	225000	usd
CY2021Q3	mssv	Payment Amount PaymentAmount	50000	usd
CY2022	mssv	Professional Service Consulting Description ProfessionalServiceConsultingDescription	In consideration of mutual covenants set forth in the Professional Service Consulting Agreement, Dave Christensen, current Director, President, Chief Executive Officer, Chief Financial Officer and Secretary, shall be compensated monthly based on annual rate of $90,000, starting January 1, 2022. Additionally, the agreement includes an issuance of 896 shares of Series DD Preferred Stock of the Company. An amount of 448 shares were issued on August 18, 2021 and the remaining 448 were issued February 18, 2022.
CY2022	us-gaap	Other Expenses OtherExpenses	503552	usd
CY2022	mssv	Professional Service Consulting Agreement Description ProfessionalServiceConsultingAgreementDescription	In consideration of mutual covenants set forth in the Professional Service Consulting Agreement, Dave Christensen, current Director, President, Chief Executive Officer, Chief Financial Officer and Secretary, shall be compensated monthly based on an annual rate of $90,000 starting January 1, 2022. Additionally, the agreement includes an issuance of 896 shares of Series DD Preferred Stock of the Company. An amount of 448 shares were issued on August 18, 2021 and the remaining 448 were issued on February 18, 2022.
CY2022	us-gaap	Payments For Fees PaymentsForFees	90000	usd
CY2021	us-gaap	Payments For Fees PaymentsForFees	60000	usd
CY2021Q4	mssv	Escrow Amount EscrowAmount	8200000	usd
CY2021Q3	mssv	Stock Purchase Percentage StockPurchasePercentage	1	pure
CY2019Q1	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	20991	usd
CY2019Q1	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	504.94	usd
CY2022	mssv	Outstanding Auto Loan OutstandingAutoLoan	0	usd
CY2022	mssv	Aggregates Amount AggregatesAmount	200390	usd
	mssv	Aggregates Amount AggregatesAmount	101175	usd
CY2017	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	282500	usd
CY2021Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	300000	usd
CY2021Q2	mssv	Issued Shares Of Common Stock IssuedSharesOfCommonStock	1092866	shares
CY2021Q2	mssv	Common Stock Settlement Amount CommonStockSettlementAmount	213109	usd
CY2021Q2	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Outstanding Balance CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesOutstandingBalance	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0.275	pure
CY2021Q4	us-gaap	Area Of Land AreaOfLand	1647	sqm
CY2021	us-gaap	Payments For Rent PaymentsForRent	2714	usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	5588	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	44097	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	96135	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43536	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	186269	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22909	usd
CY2022	mssv	Equipment And Leaseholds Purchased EquipmentAndLeaseholdsPurchased	55199	usd
CY2021	mssv	Equipment And Leaseholds Purchased EquipmentAndLeaseholdsPurchased	40858	usd
CY2021Q3	mssv	Outstanding Shares Percentage OutstandingSharesPercentage	1	pure
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	225000	usd
CY2022	us-gaap	Convertible Preferred Stock Terms Of Conversion ConvertiblePreferredStockTermsOfConversion	The preliminary purchase price for the merger was determined to be $6.229 million, which consists of (i) 1 million shares of Series AA preferred stock valued at approximately $964,000, (ii) 8,974 shares of Series DD preferred stock valued at approximately $5.04 million and (iii) $225,000 in cash of which $175,000 was advanced in prior to closing of the transaction.
CY2022Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	87700	usd
CY2021Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	87700	usd
CY2022	mssv	Intellectual Property Licenses IntellectualPropertyLicenses	363000	usd
CY2021	mssv	Intellectual Property Licenses IntellectualPropertyLicenses	363000	usd
CY2022	mssv	Customer Base CustomerBase	37000	usd
CY2021	mssv	Customer Base CustomerBase	37000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	487700	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	487700	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	133616	usd
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	36076	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	354084	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	451624	usd
CY2022	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2022	mssv	Amortization Expense Intellectual Property AmortizationExpenseIntellectualProperty	97540	usd
CY2021	mssv	Amortization Expense Intellectual Property AmortizationExpenseIntellectualProperty	36076	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	32568	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2714	usd
CY2022Q4	mssv	Total Undiscounted Cash Payments TotalUndiscountedCashPayments	35282	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	1319	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	33963	usd
CY2021Q3	mssv	Stock Purchase Agreement Percentage StockPurchaseAgreementPercentage	1	pure
CY2021Q3	us-gaap	Cash Cash	225000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1156433	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	353840	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	802593	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4421887	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3619294	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4421887	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3619294	usd
CY2022	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	$22,240,131
CY2022	mssv	Monthly Rent MonthlyRent	2714	usd
CY2022Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	5588	usd
CY2022	us-gaap	Goodwill Change In Goodwill Allocation Description GoodwillChangeInGoodwillAllocationDescription	The preliminary purchase price for the merger was determined to be $6.229 million, which consists of (i) 1 million shares of Series AA preferred stock valued at approximately $964,000, (ii) 8,974 shares of Series DD preferred stock valued at approximately $5.04 million and (iii) $225,000 in cash of which $175,000 was advanced prior to closing of the transaction (See Note 10).
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5805438	usd
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	5805438	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	5805438	usd
CY2022Q4	mssv	Interest Percentage InterestPercentage	1	pure
CY2022	us-gaap	Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Net Of Tax DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalNetOfTax	68313	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q4	mssv	Liabilities Held For Sale LiabilitiesHeldForSale		usd
CY2022Q4	mssv	Stock Payablerelated Party StockPayablerelatedParty		usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense		usd
CY2022	mssv	Settlement Of Lawsuit SettlementOfLawsuit		usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2022	mssv	Loss On Legal Settlement LossOnLegalSettlement		usd
CY2022	mssv	Preferred Shares Issued For Services PreferredSharesIssuedForServices		usd
CY2022	mssv	Imputed Interest On Debt ImputedInterestOnDebt		usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets		usd
CY2022	mssv	Increase Decrease Stock Payable IncreaseDecreaseStockPayable		usd
CY2021	mssv	Depreciation Discontinued Operations DepreciationDiscontinuedOperations		usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022	mssv	Proceeds From Note Receivable ProceedsFromNoteReceivable		usd
CY2022	mssv	Loan To Nonaffiliate LoanToNonaffiliate		usd
CY2022	mssv	Debt Restructure DebtRestructure		usd
CY2022	mssv	Cancellations Of Preferred Series Bb CancellationsOfPreferredSeriesBB		usd
CY2022	mssv	Cancellation Of Preferred Series Cc CancellationOfPreferredSeriesCC		usd
CY2022	mssv	Issuance Of Preferred Series Aa For Acquisition IssuanceOfPreferredSeriesAAForAcquisition		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Stock Issued1 StockIssued1		usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022	mssv	Issuance Of Preferred Series Dd For Acquisitions IssuanceOfPreferredSeriesDDForAcquisitions		usd
CY2022	mssv	Discount Issued On Convertible Debt DiscountIssuedOnConvertibleDebt		usd
CY2022	mssv	Expected Dividend Yields ExpectedDividendYields
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet		usd
CY2021	mssv	Derivative Instruments Conversions DerivativeInstrumentsConversions		usd
CY2022	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions		usd
CY2022	mssv	Derivative Instruments Conversions DerivativeInstrumentsConversions		usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest		usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour		usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2020Q4	us-gaap	Goodwill Gross GoodwillGross		usd
CY2021	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax		usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2022	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001760026

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
mssv-20221231_cal.xml	Edgar Link	unprocessable
0001213900-23-029942-index-headers.html	Edgar Link	pending
0001213900-23-029942-index.html	Edgar Link	pending
0001213900-23-029942.txt	Edgar Link	pending
0001213900-23-029942-xbrl.zip	Edgar Link	pending
f10k2022ex10-10_mesonumis.htm	Edgar Link	pending
f10k2022ex10-5_mesonumis.htm	Edgar Link	pending
f10k2022ex10-6_mesonumis.htm	Edgar Link	pending
f10k2022ex10-7_mesonumis.htm	Edgar Link	pending
f10k2022ex10-8_mesonumis.htm	Edgar Link	pending
f10k2022ex10-9_mesonumis.htm	Edgar Link	pending
f10k2022ex21-1_mesonumis.htm	Edgar Link	pending
f10k2022ex31-1_mesonumis.htm	Edgar Link	pending
f10k2022ex31-2_mesonumis.htm	Edgar Link	pending
f10k2022ex32-1_mesonumis.htm	Edgar Link	pending
f10k2022ex4-1_mesonumis.htm	Edgar Link	pending
f10k2022ex4-2_mesonumis.htm	Edgar Link	pending
f10k2022ex4-3_mesonumis.htm	Edgar Link	pending
f10k2022ex4-4_mesonumis.htm	Edgar Link	pending
f10k2022ex4-5_mesonumis.htm	Edgar Link	pending
f10k2022_mesonumis.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mssv-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
mssv-20221231_def.xml	Edgar Link	unprocessable
mssv-20221231_lab.xml	Edgar Link	unprocessable
mssv-20221231_pre.xml	Edgar Link	unprocessable
f10k2022_mesonumis_htm.xml	Edgar Link	completed
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMTG
Regenerative Medical Technology Group Inc. Stock $rmtg

2023 Q1 Form 10-K Financial Statement

#000121390023029942 Filed on April 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTG Regenerative Medical Technology Group Inc. Stock $rmtg

2023 Q1 Form 10-K Financial Statement

#000121390023029942 Filed on April 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTG
Regenerative Medical Technology Group Inc. Stock $rmtg